TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

LATEST NEWS

Jim Cramer's Take on 17 Consumer Stocks if You're Fearing Deflation
MERGERS AND ACQUISITIONS

Johnson & Johnson Looks for New Deal That's Just Right

Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

The Nominees for Best Biopharma CEO of 2015 Are...

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Here's How Oil, the Fed and China Pushed Markets Up

Denbury Resources (DNR) Stock Drops on Falling Oil Prices
MARKETS

AbbVie (ABBV) Stock Price Target Raised at Deutsche Bank

Citigroup (C) Stock Higher Today After Earnings Beat
MARKETS

AbbVie (ABBV) Stock Gains After IMBRUVICA Receives EU Regulatory Approval

5 Best-Positioned Biotech Stocks on Brexit Volatility
INVESTING

AXON, REGN, BURL, FIVE: Jim Cramer's Views

Weatherford Int'l. (WFT) Stock Sliding Amid Lower Oil Prices
MARKETS

AbbVie (ABBV) Stock Gains on Bullish JPMorgan Note

As the Trump Rally Resumes, Buy This Battered Health Sector Blue-Chip
INVESTING

Jim Cramer -- Here's Why I'm Buy, Buy, Buying J&J and Selling Merck

What to Expect When Freeport McMoRan (FCX) Reports First-Quarter Earnings Tomorrow
MARKETS

AbbVie (ABBV) Stock Gains After Completing $21 Billion Pharmacyclics Purchase

Cramer: I'm Buying J&J as It Has the Most Upside of Major Pharmas
VIDEO

Cramer: I'm Buying J&J as It Has the Most Upside of Major Pharmas

Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

New Lifetime High For Pharmacyclics (PCYC)

Stock Market Today - Corporate Profitability Trends, Global Marco Economy
INVESTING

Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon

A Guide to Future Fed Decisions and You
INVESTING

Jim Cramer -- Why Is Janet Yellen Suddenly a Stock Commentator?

AbbVie Falls After Missing Top- and Bottom-Line Estimates
MERGERS AND ACQUISITIONS

AbbVie Refiles for Antitrust Review of Pharmacyclics Deal

Will Amazon.com (AMZN) Stock be Affected by New E-Book Author Royalty Plan?
MARKETS

Johnson & Johnson (JNJ) Stock Climbing Today on Better Than Expected First Quarter Earnings

Continental Resources (CLR) Stock Rises Today as Oil Prices Rally
MARKETS

What to Expect When Johnson & Johnson (JNJ) Reports First-Quarter Earnings Tomorrow

Dick's Sporting Goods (DKS) Stock Declines Pre-Market on Weak First Quarter SSS
MARKETS

AbbVie (ABBV) Stock Opens Higher, Then Falls Today Following Analyst Upgrade

Stock Building Supply Merger Creates a $1.5 Billion Company
MERGERS AND ACQUISITIONS

First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007

Immunogen Tanks After Ovarian Cancer Drug Study Fails to Meet Endpoint
INVESTING

Jim Cramer -- Mylan's Move to Acquire Perrigo a Prescription for Success

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
INVESTING

Biotech Merger Monday Doesn't Squash Biotech Bubble Debate

Join Jim Cramer and Jack Mohr for Exclusive Market Update
INVESTING

Biotech, Chips Stand Their Ground; Be Careful What You Wish For: Jim Cramer's Best Blogs

Touch Technology Provider's Shares on the Rise
INVESTING

BioMarin Rises Amid Takeover Speculation, Price Target Raises

3 Basic Materials Stocks Driving The Sector Higher
MARKETS

3 Stocks Reiterated As A Hold: PCYC, LNKD, PM

'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing

Jim Cramer Digs Into Dozens of Charts, Finds 7 Pillars of Health Care Strength
INVESTING

Jim Cramer Digs Into Dozens of Charts, Finds 7 Pillars of Health Care Strength